Label: NOVOMINSYRUP- caffeine anhydrous, meclizine hydrochloride hydrate, pyridoxine hydrochloride liquid

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated January 23, 2023

If you are a consumer or patient please visit this version.

  • ACTIVE INGREDIENT

    Caffeine Anhydrous, Meclizine Hydrochloride Hydrate, Pyridoxine Hydrochloride

  • PURPOSE

    ■ throw up■ whirl ■ headache

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children

  • INDICATIONS & USAGE

    ■ adult and children 15 years of age and older: 1 pack 30 minutes before boarding.

    ■ children under 15 years of age: ask a doctor

  • WARNINGS

    Ask a doctor before use if you have taking a prescription drug.

    When using this product

    ■ Do not take more than 3 pack in 24 hours

    ■ If you take an additional dose, take it after 4 hours or more

    Keep out of reach of children

  • INACTIVE INGREDIENT

    concentrated glycerin, malt syrup, high fructose 55

  • DOSAGE & ADMINISTRATION

    for oral use

  • PRINCIPAL DISPLAY PANEL

    label

  • INGREDIENTS AND APPEARANCE
    NOVOMINSYRUP 
    caffeine anhydrous, meclizine hydrochloride hydrate, pyridoxine hydrochloride liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72988-0034
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CAFFEINE (UNII: 3G6A5W338E) (CAFFEINE - UNII:3G6A5W338E) CAFFEINE20 mg  in 6 mL
    MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO) (MECLIZINE - UNII:3L5TQ84570) MECLIZINE HYDROCHLORIDE25 mg  in 6 mL
    PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE HYDROCHLORIDE5 mg  in 6 mL
    Inactive Ingredients
    Ingredient NameStrength
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72988-0034-16 mL in 1 POUCH; Type 0: Not a Combination Product01/23/2023
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other01/23/2023
    Labeler - Lydia Co., Ltd. (695735569)
    Registrant - Lydia Co., Ltd. (695735569)
    Establishment
    NameAddressID/FEIBusiness Operations
    Lydia Co., Ltd.695735569manufacture(72988-0034)